Cetera Investment Advisers - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 33 filers reported holding QUALIGEN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cetera Investment Advisers ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$90,000
-17.4%
45,025
+11.8%
0.00%
-50.0%
Q1 2021$109,000
-9.9%
40,2750.0%0.00%0.0%
Q4 2020$121,000
+45.8%
40,275
+140.2%
0.00%
-71.4%
Q3 2020$83,00016,7650.01%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
HighMark Wealth Management LLC 80,094$159,0000.12%
PERKINS CAPITAL MANAGEMENT INC 53,304$106,0000.06%
HATTON CONSULTING, INC. 37,195$74,0000.06%
CRA Financial Services, LLC 19,957$40,0000.01%
StoneX Group Inc. 13,442$27,0000.00%
WEDBUSH SECURITIES INC 32,228$64,0000.00%
QS Investors, LLC 82,000$164,0000.00%
Retirement Group, LLC 2,500$5,0000.00%
Cetera Investment Advisers 45,025$90,0000.00%
COMMONWEALTH EQUITY SERVICES, LLC 137,510$273,0000.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders